Skip to main content
Sam-A Pharm. Co. Ltd logo

Sam-A Pharm. Co. Ltd — Investor Relations & Filings

Ticker · 009300 ISIN · KR7009300005 KO Manufacturing
Filings indexed 105 across all filing types
Latest filing 2023-03-10 AGM Information
Country KR South Korea
Listing KO 009300

About Sam-A Pharm. Co. Ltd

https://www.samapharm.co.kr/eng/main201…

Sam-A Pharm. Co. Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of a range of pharmaceutical products. The company specializes in several therapeutic areas, with a primary focus on treatments for respiratory and dermatological conditions. Its portfolio also includes antipyretic, analgesic, and anti-inflammatory medications. Founded in 1945, Sam-A Pharm. operates manufacturing facilities that adhere to high-quality production standards, equivalent to EU-GMP, reflecting its long-standing commitment to improving health and quality of life.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal notification filed by Sam-A Pharmaceutical regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the operational reasons for this scheduling choice and references the relevant regulatory framework (Commercial Act). Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or the results of the meeting, it falls under the general regulatory filing category.
2023-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Sama Pharmaceutical) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for material financial changes. Since it provides key financial highlights and performance metrics rather than a full annual report or a simple publication notice, it falls under the Earnings Release category as it serves as the initial announcement of financial results. FY 2022
2023-02-28 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Sam-A Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2023-02-28 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Sam-A Pharm Co., Ltd. (삼아제약 주식회사) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial data, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (specifically due to inheritance). This type of filing is used to notify the market of significant changes in shareholding levels, which falls under the 'Major Shareholding Notification' category.
2022-09-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by insiders (executives/major shareholders) to report changes in their shareholdings. This corresponds to the 'Director's Dealing' category, which covers insider trades and changes in ownership by company directors and executives.
2022-09-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.